Revolution Medicines, Inc. - *W EXP 12/17/202 (RVMDW)

CUSIP: 76155X118

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / *W EXP 12/17/202
Total 13F shares
8,066,230
Share change
+4,925
Total reported value
$2,455,615
Price per share
$0.30
Number of holders
21
Value change
+$3,514
Number of buys
1
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 76155X118?
CUSIP 76155X118 identifies RVMDW - Revolution Medicines, Inc. - *W EXP 12/17/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Revolution Medicines, Inc. - *W EXP 12/17/202 (RVMDW) as of Q3 2025

As of 30 Sep 2025, Revolution Medicines, Inc. - *W EXP 12/17/202 (RVMDW) was held by 21 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,066,230 shares. The largest 10 holders included LMR Partners LLP, D. E. Shaw & Co., Inc., PRICE T ROWE ASSOCIATES INC /MD/, ADAGE CAPITAL PARTNERS GP, L.L.C., Lunate Capital Ltd, ARISTEIA CAPITAL, L.L.C., SOROS CAPITAL MANAGEMENT LLC, PERCEPTIVE ADVISORS LLC, TORONTO DOMINION BANK, and Bleichroeder LP. This page lists 21 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.